The Hirschsprung disease drug market is a specialized segment of the pharmaceutical industry, providing therapies and interventions for individuals with Hirschsprung disease, a congenital gastrointestinal disorder that affects the large intestine's ability to function properly. With rising prevalence of Hirschsprung disease, increasing awareness, advancements in drug therapies, and growing...